Winnie Yeo

31.9k citations

423 papers · 17.7k indexed · 1 hit paper · h-index 63

Impact in

Hepatology top 0.05%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
Oncology top 0.2%
- Viral-associated cancers and disorders

Papers in

Hepatology 111
- Hepatocellular Carcinoma Treatment and Prognosis 87
- Hepatitis C virus research 28
Oncology 227
- Cancer Treatment and Pharmacology 37

Co-authors: Philip J. Johnson Frankie Mo Tony Mok Anthony T.�C. Chan Stephen L. Chan Wing Ming Ho Paul B.S. Lai Paul K.S. Chan
Journals: Journal of Clinical Oncology (53 papers)Annals of Oncology (16 papers)Cancer Chemotherapy and Pharmacology (11 papers)Cancer (11 papers)Journal of Medical Virology (10 papers)
Partner nations: Hong Kong China South Korea

In The Last Decade

Winnie Yeo

411 papers receiving 17.3k citations

Hit Papers

align trajectories log scale

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade 2014 · 1.8k citations

Peers

Countries citing papers authored by Winnie Yeo

Since Specialization

Citations

This map shows the geographic impact of Winnie Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winnie Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winnie Yeo more than expected).

Fields of papers citing papers by Winnie Yeo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winnie Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winnie Yeo. The network helps show where Winnie Yeo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Winnie Yeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Winnie Yeo Line = papers co-authored together Winnie Yeo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates Future Oncology ·Winnie Yeo, Giampaolo Bianchini, Javier Cortés, Luca Licata, María Vidal, Hirotoshi Iihara, Eric Roeland, Karin Jordan, Florian Scotté, Lee S. Schwartzberg, Rudolph M. Navari, Matti Aapro, Hope S. Rugo	2025	0
2	Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Drug Safety ·Joanne Chiu, Soo Chin Lee, Jcm Ho, Yeon Hee Park, Ta‐Chung Chao, Sung‐Bae Kim, Elgene Lim, Ching‐Hung Lin, Sherene Loi, Su Ying Low, Lynette Teo, Winnie Yeo, Rebecca Dent	2023	16
3	A Predictive Model for Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy Using Machine Learning Isaac Kim, Jakree Koosakul, Seung Ah Lee, Winnie Yeo, А.М. Кемешова	2021	2
4	Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040 UCL Discovery (University College London) ·Bruno Sangro, Ignacio Melero, B Broc, Chiun Hsu, Mitsuhiro Kudo, Tae‐Yop Kim, Pooja Kumari Jat, Jörg Trojan, María Laura Arteaga-García, T Meyer, Y-K. Kang, Winnie Yeo, Arun Chopra, Margarita María Camacho Castro, Christine Dela Cruz, Hui Zhao, Jaclyn Neely, H. G. Farquhar, Γεώργιος Βλυσίδης	2017	12
5	A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma Cancer ·Stephen L. Chan, Winnie Yeo, Frankie Mo, Anthony W.H. Chan, Jane Koh, Leung Li, Edwin P. Hui, Charing C. N. Chong, Paul B.S. Lai, Tony Mok, Simon C.H. Yu	2017	24
6	Applicability of albumin‐bilirubin‐based Japan integrated staging score in hepatitis B‐associated hepatocellular carcinoma Journal of Gastroenterology and Hepatology ·Anthony W.H. Chan, Charing C. N. Chong, Frankie Mo, John Wong, Winnie Yeo, Philip J. Johnson, Simon C.H. Yu, Paul B.S. Lai, Anthony T.�C. Chan, Ka‐Fai To, Stephen L. Chan	2016	42
7	Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma Liver International ·Stephen L. Chan, Anthony W.H. Chan, Patricia Silvana, H Akhmad, Frankie Mo, Charles Chan, 河合伸一, C. T. Lockwood, Charing C. N. Chong, Anthony T.�C. Chan, Tony Mok, Winnie Yeo	2016	32
8	Incorporating albumin–bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma Journal of Gastroenterology and Hepatology ·Anthony W.H. Chan, Charing C. N. Chong, Frankie Mo, John Wong, Winnie Yeo, Philip J. Johnson, Simon C.H. Yu, Paul B.S. Lai, Anthony T.�C. Chan, Ka‐Fai To, Stephen L. Chan	2016	43
9	Applicability of BALAD score in prognostication of hepatitis B‐related hepatocellular carcinoma Journal of Gastroenterology and Hepatology ·Stephen L. Chan, Frankie Mo, Philip J. Johnson, Leung Li, Nelson L.S. Tang, Herbert H. Loong, Anthony W.H. Chan, Jane Koh, Anthony T.�C. Chan, Winnie Yeo	2015	11
10	A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma Clinical Cancer Research ·Ho Yeong Lim, Jeong Heo, Hye Jin Choi, Cheng-Yao Lin, Jung‐Hwan Yoon, Chiun Hsu, Kun‐Ming Rau, Ronnie T. P. Poon, Winnie Yeo, Joong‐Won Park, Miah Hiang Tay, Wen-Son Hsieh, Christian Kappeler, Prabhu Rajagopalan, Heiko Krissel, Michael Jeffers, Chia‐Jui Yen, Won Young Tak	2014	86
11	Correction: Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients PLoS ONE ·Lingzhi Wang, MARINA BURDMAN DA FONTOURA, Winnie Yeo, Simões Fernandes F, Ibrahim Rashid Al Shamsi, Jieying Amelia Lau, C. Theresa Vincent, Andrea Li‐Ann Wong, Luis Meléndez, Robert C. Lim, Soo Chin Lee, Paul C. Ho, How-Sung Lee, Anthony K.C. Chan, Sherry S. Ansher, Mark J. Ratain, Boon-Cher Goh	2014	1
12	Phase III, Multicenter, Randomized Trial of Maintenance Chemotherapy Versus Observation in Patients With Metastatic Breast Cancer After Achieving Disease Control With Six Cycles of Gemcitabine Plus Paclitaxel As First-Line Chemotherapy: KCSG-BR07-02 Journal of Clinical Oncology ·Winnie Yeo, Kyung Hae Jung, Seock‐Ah Im, Joohyuk Sohn, Jungsil Ro, Jin Hee Ahn, Sung‐Bae Kim, Byung‐Ho Nam, Do Youn Oh, Sae‐Won Han, Soo Hyun Lee, In Hae Park, Keun Seok Lee, Jee Hyun Kim, Seok Yun Kang, Moon Hee Lee, Hee Sook Park, Jin Seok Ahn, Young‐Hyuck Im	2013	54
13	The evolution of supportive care needs trajectories in women with advanced breast cancer during the 12 months following diagnosis Supportive Care in Cancer ·Wwt Lam, Janice Tsang, Winnie Yeo, Joyce Suen, Wing Ming Ho, T. Yau, Inda Soong, Yapeng He, Ava Kwong, Dacita Suen, Wing Kin Sze, Alice Ng, Afaf Girgis, Richard Fielding	2013	38
14	HER2-positive metastatic breast cancer: New agents on the horizon Hong Kong Journal of Radiology ·Winnie Yeo	2012	1
15	Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy Clinical Cancer Research ·Winnie Yeo, Sang Kyun Sohn, Jong Gwang Kim, Haolin Tian, Hong Song, Min Kyoung Kim, Laela Auleani, 土岐正雄, Hyeoung Joon Kim, Dong Hwan Kim	2009	26
16	The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma Blood ·Sarah Park, Jeeyun Lee, Young Hyeh Ko, Arum Han, Hyun Jung Jun, Sang Chul Lee, In Gyu Hwang, Winnie Yeo, Jin Seok Ahn, Chul Won Jung, Kihyun Kım, Yong Chan Ahn, Won Ki Kang, Keunchil Park, Won Seog Kim	2007	242
17	Does Income Smoothing Reduce the Cost of Capital Korean Accounting Journal ·Yang Dong Hoon, Winnie Yeo, R.H.G, Bert Hudgins	2007	1
18	Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Research and Treatment ·Keun Seok Lee, Hyun Cheol Chung, Seock Ah Im, Winnie Yeo, Chul Soo Kim, Sung‐Bae Kim, Sun Young Rha, Min Young Lee, Jungsil Ro	2007	402
19	A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma JNCI Journal of the National Cancer Institute ·Winnie Yeo, Tony Mok, Benny Zee, Thomas W. T. Leung, Paul B.S. Lai, Wan Yee Lau, Jane Koh, Frankie Mo, Simon C.H. Yu, Anthony T.�C. Chan, Pun Hui, Brigette Ma, Kwok Chi Lam, Wing Ming Ho, Herman Wong, Voronin Sergey Eduardovich, Philip J. Johnson	2005	467
20	No Association between Catalase Gene Polymorphism and Gastric Carcinoma and Hepatocellular Carcinoma in Koreans Cancer Research and Treatment ·Ji Hyun Lee, Hou Qingsheng, Chang‐Soo Lee, 曾雪玫, Su Youn Nam, Kat Jones, Giuseppe SURICO, Hee Jae Lee, A. M. Kargatova, Italo Herbert Lucena Cavalcante, Sung Vin Yim, Jae‐Young Cho, Winnie Yeo	2002	5

About Winnie Yeo

Winnie Yeo is a scholar working on Hepatology, Oncology, Cancer Research, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 423 papers that have together received 17.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (87 papers), Liver Disease Diagnosis and Treatment (46 papers), Hepatitis B Virus Studies (38 papers), Lung Cancer Treatments and Mutations (38 papers), Breast Cancer Treatment Studies (37 papers), Cancer Treatment and Pharmacology (37 papers), Lymphoma Diagnosis and Treatment (33 papers) and Hepatitis C virus research (28 papers). The work is most often cited by research in Hepatology (7.3k citations), Oncology (6.5k citations), Otorhinolaryngology (812 citations), Epidemiology (6.0k citations) and Cancer Research (2.2k citations). Winnie Yeo has collaborated with scholars based in Hong Kong, China and South Korea. Frequent co-authors include Philip J. Johnson, Frankie Mo, Tony Mok, Anthony T.�C. Chan, Stephen L. Chan, Wing Ming Ho, Paul B.S. Lai, Paul K.S. Chan, Benny Zee and Sheng Zhong. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Cancer and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact